1. Home
  2. Detail

@pina_ramadani:

pinaaayyyy
pinaaayyyy
Open In TikTok:
Region: ID
Sunday 06 July 2025 09:26:43 GMT
11116
558
7
8

Music

Download

No Watermark .mp4 (2.37MB) Watermark .mp4 (0MB) Music .mp3

Comments

byyto12
Risee :
mirip
2025-07-06 11:46:24
0
_34567891012
lll :
salfok sama adenya.. 😳
2025-07-07 04:16:22
0
_as01122025
budug shop :
panutan pokonamah
2025-07-07 03:08:35
0
rskyta13
bntaanggg :
anjayyy iqalll😭
2025-09-14 04:35:31
0
hacay_
. :
☺️
2025-07-06 09:42:16
0
ferdiyansah08_
𝑭𝒆𝒓𝒅𝒊𝒚𝒂𝒏𝒔𝒂𝒉 :
💙
2025-07-06 09:39:21
0
ardiann.05
Ardiann.05 :
🤣
2025-08-02 17:52:17
0
To see more videos from user @pina_ramadani, please go to the Tikwm homepage.

Other Videos
ima fucking WRETCH 👁️ #selfie #horrorart #horror
ima fucking WRETCH 👁️ #selfie #horrorart #horror


Lots of lessons learnt! #SmallBusiness #businesstips #activewear #womeninbusiness #education
Lots of lessons learnt! #SmallBusiness #businesstips #activewear #womeninbusiness #education
#paris #@TANA 🤴🏾
#paris #@TANA 🤴🏾
The rumors of a CRO collapse have been greatly exaggerated. While the market took a hit between 2022 and 2024, the latest numbers from heavy hitters like IQVIA and ICON tell a completely different story. With IQVIA pulling in $16.3 billion in revenue and boasting a massive $32 billion backlog, plus ICON showing similar strength, it’s clear the tide has turned. As biotech funding recovers, the demand for outsourced trials is bouncing back in a big way. The capital markets are signaling growth, and this sector is proving to be more resilient than the skeptics thought. #biotech #CRO #investing #pharma #markettrends
The rumors of a CRO collapse have been greatly exaggerated. While the market took a hit between 2022 and 2024, the latest numbers from heavy hitters like IQVIA and ICON tell a completely different story. With IQVIA pulling in $16.3 billion in revenue and boasting a massive $32 billion backlog, plus ICON showing similar strength, it’s clear the tide has turned. As biotech funding recovers, the demand for outsourced trials is bouncing back in a big way. The capital markets are signaling growth, and this sector is proving to be more resilient than the skeptics thought. #biotech #CRO #investing #pharma #markettrends

About

Legal